Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 1
2020 2
2021 5
2022 11
2023 9
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, González-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M; HELIOS-A Collaborators. Adams D, et al. Amyloid. 2023 Mar;30(1):1-9. doi: 10.1080/13506129.2022.2091985. Epub 2022 Jul 23. Amyloid. 2023. PMID: 35875890 Free article. Clinical Trial.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
Emerging multisystem biomarkers in hereditary transthyretin amyloidosis: a pilot study.
Luigetti M, Vitali F, Romano A, Sciarrone MA, Guglielmino V, Ardito M, Sabino A, Servidei S, Piro G, Carbone C, Graziani F, Lillo R, Ferraro PM, Primiano G. Luigetti M, et al. Among authors: guglielmino v. Sci Rep. 2024 Aug 7;14(1):18281. doi: 10.1038/s41598-024-69123-x. Sci Rep. 2024. PMID: 39112608 Free PMC article.
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy.
Gentile L, Mazzeo A, Briani C, Casagrande S, De Luca M, Fabrizi GM, Gagliardi C, Gemelli C, Forcina F, Grandis M, Guglielmino V, Iabichella G, Leonardi L, Lozza A, Manganelli F, Mussinelli R, My F, Occhipinti G, Fenu S, Russo M, Romano A, Salvalaggio A, Tagliapietra M, Tozza S, Palladini G, Obici L, Luigetti M. Gentile L, et al. Among authors: guglielmino v. Neurol Sci. 2024 Sep;45(9):4563-4571. doi: 10.1007/s10072-024-07494-9. Epub 2024 Apr 16. Neurol Sci. 2024. PMID: 38622453 Free PMC article.
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN).
Galosi E, Costanzo R, Forcina F, Morino S, Antonini G, Salvetti M, Lauletta A, Luigetti M, Romano A, Primiano G, Guglielmino V, Fionda L, Garibaldi M, Esposito N, Falco P, di Pietro G, Truini A, Leonardi L. Galosi E, et al. Among authors: guglielmino v. Neurol Sci. 2024 Oct;45(10):5023-5032. doi: 10.1007/s10072-024-07562-0. Epub 2024 May 3. Neurol Sci. 2024. PMID: 38700599 Free PMC article.
Early detection of nerve involvement in presymptomatic TTR mutation carriers: exploring potential markers of disease onset.
Romano A, Guglielmino V, Bisogni G, Di Paolantonio A, Truini A, Minnella AM, Sciarrone MA, Vitali F, Maceroni M, Galosi E, Sabatelli M, Luigetti M. Romano A, et al. Among authors: guglielmino v. Neurol Sci. 2024 Apr;45(4):1675-1684. doi: 10.1007/s10072-023-07177-x. Epub 2023 Nov 8. Neurol Sci. 2024. PMID: 37938457 Free PMC article.
Quantitative sensory testing and skin biopsy findings in late-onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO).
Leonardi L, Costanzo R, Forcina F, Morino S, Antonini G, Salvetti M, Luigetti M, Romano A, Primiano G, Guglielmino V, Fionda L, Garibaldi M, Lauletta A, Rossini E, Tufano L, Ceccanti M, Esposito N, Falco P, di Pietro G, Truini A, Galosi E. Leonardi L, et al. Among authors: guglielmino v. J Peripher Nerv Syst. 2023 Sep;28(3):390-397. doi: 10.1111/jns.12586. Epub 2023 Aug 16. J Peripher Nerv Syst. 2023. PMID: 37535421
Popeye Sign: Look at the Heart (and the Nerves).
Romano A, Guglielmino V, Sciarrone MA, Vitali F, Luigetti M. Romano A, et al. Among authors: guglielmino v. Eur Neurol. 2023;86(4):285-286. doi: 10.1159/000530453. Epub 2023 Mar 31. Eur Neurol. 2023. PMID: 37004505 No abstract available.
34 results